![](https://www.microbiometimes.com/wp-content/uploads/2018/06/shutterstock_331193828-326x245.jpg)
Pharma & Human Health
Microbiotica Collaborates with University of Adelaide to Develop a Novel Microbial Therapy for Ulcerative Colitis
Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its programme to develop a defined bacterial product for ulcerative colitis (UC). […]